Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies

Wanghao Liu, Xiaoying Sun

Open source

DOI
10.1186/s12882-024-03910-6
Published
2024-12-20
Container
BMC Nephrology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12882-024-03910-6,
  title = {Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies},
  author = {Wanghao Liu and Xiaoying Sun},
  year = {2024},
  journal = {BMC Nephrology},
  doi = {10.1186/s12882-024-03910-6},
  url = {https://doi.org/10.1186/s12882-024-03910-6}
}

RIS

TY  - JOUR
TI  - Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies
AU  - Wanghao Liu
AU  - Xiaoying Sun
PY  - 2024
JO  - BMC Nephrology
DO  - 10.1186/s12882-024-03910-6
UR  - https://doi.org/10.1186/s12882-024-03910-6
ER  - 

APA

Liu, W., & Sun, X. (2024). Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies. BMC Nephrology. https://doi.org/10.1186/s12882-024-03910-6

Source records